Literature DB >> 8154013

Snake bite and antivenom complications in Belo Horizonte, Brazil.

W T Caiaffa1, D Vlahov, C M Antunes, H R de Oliveira, C R Diniz.   

Abstract

Factors associated with clinical complications of snake bite and antivenom therapy were studied in 310 hospital patients admitted with snake bite over 6 years to a tertiary referral hospital in Belo Horizonte, southeast Brazil. Overall, 17.4% had early clinical complications including tissue loss associated with abscess and necrosis, acute renal failure, shock, acute lung oedema and intracranial haemorrhage. 3% had permanent sequelae, caused by muscle contractures and amputations, chronic renal failure, or death. Early complications were associated with the following: age under 9 years (P = 0.04), residence in a rural area (P = 0.04), and a delay of more than 8 h in seeking clinical care (P < 0.01). Antivenom was administered to 98.1% of patients; 13.8% presented with anaphylaxis and 11.8% with pyrexia. Individuals from a rural area had a higher occurrence of anaphylactic reactions (P = 0.03). Neither anaphylaxis nor pyrexia was linked with antivenom type and dosage. This study suggested that antivenom might be associated with a reduced risk of serious injuries related to snake bite, especially when administered within the first 8 h. Complications appeared to be a far greater risk than adverse reactions to the antivenom.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8154013     DOI: 10.1016/0035-9203(94)90511-8

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  1 in total

1.  A phase IV, prospective, observational study of the clinical safety of snake antivenoms.

Authors:  Denise Christie Souto Nogueira; Iara Pinheiro Calil; Roberta Márcia Marques Dos Santos; Adebal de Andrade Filho; Gláucia Cota
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2021-12-06       Impact factor: 1.846

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.